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AbstrAct
CD4+ Tregs need to migrate from the mucosal periphery into the draining lymph 
node via CCR7 to exert their suppressive effects. In this study, we investigated whether 
CCR7 deficiency resulted in failure of immune suppression in 2% dextran sulfate 
sodium-induced colitis. Unexpectedly, intestinal inflammation was not exacerbated in 
the absence of CCR7. Expression of IL-10, a representative suppressive cytokine, was 
enhanced in CCR7KO CD8+ T cells. Colon CCR7KO CD8+ T cells reduced the activation 
of CD4+ T cells. Depletion of CD8+ T cells using anti-CD8 antibody exacerbated colitis 
in CCR7KO mice. Plasmacytoid dendritic cell numbers were also slightly increased 
during intestinal inflammation in the absence of CCR7, and the depletion of those cells 
exacerbated DSS-induced colitis in CCR7KO mice. These results suggest that CD8+ T 
cells and plasmacytoid dendritic cells have compensatory roles in immune regulation 
in the gut for impaired function of CD4+ Tregs.
IntroductIon
In mammals, the highest microbial load in the 
body is in the digestive tract, which harbors up to 1014 
commensal bacteria per gram of fecal matter [1]. The 
intestinal immune system keeps commensal microbes at 
bay by the secretion of mucin, antibacterial substances, 
and secretory IgA as well as by tightening of the epithelial 
barrier [2, 3]. Commensal microbiota competes with 
and inhibits pathogens, thus contributing to the host’s 
defense against infection [4]. Thus, it seems that the 
gastro-intestinal immune system sustains the intestinal 
microbiota to maintain a mutually beneficial state of 
intestinal homeostasis [1]. However, a breakdown of 
immune regulation can result in aberrant inflammatory 
responses such as in the case of inflammatory bowel 
diseases (IBD) [5]. 
IBD is a group of inflammatory conditions 
affecting the small and large intestine in man, including 
ulcerative colitis (UC) and Crohn’s disease (CD) [6]. 
This is a complex disease caused by the interaction of 
environmental and genetic risk factors. IL-17-producing 
Th17 cells play a key pathogenic role in chronic 
inflammatory conditions [7]. To suppress inflammation, 
several regulatory T cells (Tregs) inhibit the differentiation 
and function of pathogenic effector T cells. Foxp3+CD4+ 
Tregs make a significant contribution to immune 
suppression in the gut immune system [8]. Foxp3 
expression is essential for differentiation and suppressor 
function of CD4+ Treg cells and controls the development 
of both, naturally occurring and antigen-induced Treg cell 
lineage [9]. Foxp3-CD4+ Tregs, such as Tr1 and Th3, also 
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play a suppressive role in mucosal tissue [10]. Depletion 
of Foxp3+ Treg exacerbates intestinal inflammation even 
in the T-cell-independent colitis model [11].
CC chemokine receptor 7 (CCR7) is highly 
expressed on several immune cells such as naïve and 
central memory T cells, B cells, and mature dendritic 
cells (DCs) [12]. CCR7 ligands, CCL21 and CCL19, 
are constitutively produced in the lymph node and their 
interaction with CCR7 induces the migration of CCR7-
bearing immune cells to the lymph nodes [13]. CCR7 
deficiency results in the attenuation of immune responses 
due to the impaired migration of DCs and abnormal 
secondary lymphoid organ architecture [12]. CCR7 is also 
required for the return of T cells from the peripheral tissue 
to the lymph nodes [14]. The Foxp3+CD4+ Treg cells, 
also expressing CCR7 [15], migrate from the periphery 
towards the lymph nodes to suppress the induction of 
immune responses [16]. Thus, lack of CCR7 expression 
leads to defective lymph node localization and consequent 
functional impediment of Foxp3+CD4+ Tregs. As a result, 
CCR7KO Tregs are less effective in regulation of colitis 
[16]. Thus, CCR7 critically controls the in vivo function 
of CD4+ Tregs by mediating their localization in the 
appropriate tissue. 
Here, we investigated if CCR7 deficiency aggravates 
DSS-induced colitis. We hypothesized that CCR7 
deficiency resulted in functional defect of CD4+ Tregs, 
leading to severe intestinal pathogenesis in response to 
inflammatory stimuli. Unexpectedly, CCR7KO mice had 
less severe inflammation in the gut when compared with 
wild-type (WT) mice, although CCR7KO CD4+ Tregs 
showed impaired migration to the lymph nodes. To explain 
the resistance to DSS-induced colitis in CCR7KO mice, 
we analyzed various immune cells and the expression of 
different cytokines to determine other factors that suppress 
immune responses in the gut.
results
CCR7 deficiency did not exacerbate DSS-induced 
colitis
Foxp3+CD4+ Tregs are known to play a major role in 
immune suppression in the intestine [8]. In the absence of 
CCR7, Tregs as well as naïve T cells are unable to migrate 
from the mucosal periphery into the draining lymph 
nodes and therefore fail to exert their regulatory effect. 
In this regard, CCR7-deficient Treg cells are less capable 
of inhibiting intestinal inflammation in vivo [16]. CCR7 
deficient mice develop diarrhea autoimmune gastritis and 
exocrinopathy accompanied by the formation of mucosal 
tertiary lymphoid follicle which causes diarrhea associated 
with altered ion transport in colonocytes in absence of 
overt colitis [17]. Here, we investigated whether CCR7 
deficiency leads to severe intestinal inflammation in a 
murine dextran sulfate sodium (DSS)-induced colitis 
model. Wild-type C57BL/6 (WT) and CCR7-knock out 
(CCR7KO) mice were treated with 2% DSS in drinking 
water for 5 days and then switched to normal drinking 
water thereafter. Body weight and survival rate of mice 
was monitored in both groups. Unexpectedly, CCR7KO 
mice showed slightly alleviated weight loss (Figure 
1a) and longer survival time after severe inflammatory 
disease, compared with WT mice (Figure 1b). Although 
there was no significant difference of colon length in WT 
and CCR7KO mice at steady state, the colon length of WT 
mice was significantly decreased than that of CCR7KO 
mice after severe inflammatory disease (Figure 1c). 
Further, histological examination of colon showed that 
there was no significant difference in the pathological 
grade between WT and CCR7KO mice after DSS 
treatment (Figure 1d and 1e). Collectively, these data 
suggested that DSS-induced colitis was not aggravated in 
CCR7KO mice in comparison with WT mice, despite the 
immobilization of Foxp3+ Tregs.
Infiltration of innate immune cells in DSS-induced 
colitis slightly reduced in absence of CCR7
To assess inflammation in the colon, infiltrated 
immune cells were analyzed at Day 8 of DSS-induced 
colitis. There was a slight but insignificant decrease in 
the number of CD11b+Gr-1 high neutrophils in CCR7 KO 
mice (Figure 2a and 2b). The numbers of CD11b+F4/80+ 
macrophages and CD11c+CD11b+ dendritic cells (DCs) 
were lower in CCR7 KO mice than in the WT mice (Figure 
2c-2f). However, populations of Gr-1lowCD11b+ myeloid 
cells and CD11c+CD11b- DCs were not significantly 
different in the two groups. These data suggested that 
the colon in CCR7KO mice had less infiltration of innate 
immune cells, a representative marker of inflammation, 
than that in the WT mice with DSS-induced colitis.
cd4+ Tregs accumulated in the gut in the absence 
of CCR7
Based on the attenuated colitis shown in DSS-treated 
CCR7KO mice, we verified whether migration of CD4+ 
Tregs into the lymph node was impaired in the absence 
of CCR7. To assess this, we analyzed Foxp3+CD4+ Tregs 
from various sites of the lymphoid and peripheral gut in 
CCR7KO mice in comparison to that of WT mice. At 
the steady state, there were no significant differences 
in the percentage and absolute number of Foxp3+CD4+ 
Tregs from the SP, PLN, MLN, and PP between WT and 
CCR7KO mice (Figure 3a-3c). However, in the intestine, 
especially the SI, CCR7KO mice showed an increase in 
ratio and number of Foxp3+CD4+ Tregs, suggesting the 
possibility of peripheral accumulation of Tregs (Figure 3a-
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Figure 1: CCR7 deficiency did not exacerbate DSS-induced colitis. Mice were treated with 2% DSS for 5 days followed by 
switching to drinking water. Data are representative of three independent experiments. a. Body weight changes. Student’s t-test. **p < 0.01, 
***p < 0.001 compared between WT DSS vs CCR7KO DSS groups. b. survival rate. Log-rank (Mantel-Cox) test, compared between WT 
DSS vs CCR7KO DSS groups c. colon length; ns, not significant; *p < 0.05; one-way ANOVA, d. pathological grade from histological 
examination of colon stained with H&E; Student’s t-test, (e) representative H&E images (n = 5).
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3c). During DSS-induced colitis, CCR7KO mice showed 
a higher percentage of Foxp3+CD4+ Tregs in every tissue 
sampled than the WT mice. However, the numbers of 
Foxp3+CD4+ Tregs in the PLN and MLN of CCR7KO 
mice were lower than those in the WT mice, which was 
probably due to the impaired migration of CCR7KO 
Tregs or dendritic cells from peripheral tissues into the 
lymph nodes (Figure 3d and 3e). In contrast, CD4+ Tregs 
were accumulated in the intestines of CCR7KO mice in 
the SI as well as in the colon. Foxp3+CD4+ Tregs were 
analyzed further, based on their surface expression of 
CD25 (Supplementary Figure 1-3). We found that CD25+ 
and CD25- Foxp3+CD4+ Tregs showed similar tendency 
as Foxp3+CD4+ Tregs during both, steady state and colitis 
conditions. Next we analyzed natural and inducible CD4+ 
Tregs in the spleen, colon as well as MLN after DSS 
treatment. To distinguish the subset of CD4+ Tregs, we 
used Helios expression suggesting natural CD4+ Tregs 
specifically express Helios but inducible ones do not. 
In the MLN of CCR7 KO mice, Helios- inducible Tregs 
were decreased but Helios+ natural Tregs rather increased 
(Supplementary Figure 4). In the mucosal periphery such 
as colon, both type of Tregs were increased. To confirm 
whether impaired DC migration with CCR7 deficiency 
inhibited the generation of the effector CD4+ T cells, 
we investigated Th1/Th17 population in the MLN after 
DSS treatment. In the MLN of CCR7 KO mice, Th1 and 
Th17 populations were not decreased (Supplementary 
Figure 2: Infiltration of innate immune cells in DSS-induced colitis slightly reduced in the absence of CCR7. At Day 8 of 
DSS-induced colitis, innate immune cells were analyzed from the colon (n = 3). Data are representative of three independent experiments. 
a.-b. Gr-1+CD11b+ neutrophil population analysis, c.-d. F4/80+CD11b+ macrophages analysis, e.-f. dendritic cell analysis. Student’s t-test.
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Figure 5). Instead, Th1 population was increased in the 
MLN of CCR7 KO mice. These result suggested that 
low inflammation to CCR7 deficiency was not from 
decreased generation of effector CD4+ T cells following 
impaired DC migration. Consistent with previous reports, 
our result showed that the lack of CCR7 impaired lymph 
node homing of CD4+ Tregs from peripheral tissue, which 
is otherwise essential for their suppressive function. 
However, we could not completely rule out the possibility 
that the accumulated CD4+ Tregs in the periphery could 
still exert suppressive effect on the site of intestinal 
inflammation.
ccr7Ko cd8+ T cells in the lamina propria of 
the gut express higher level of IL-10 than those in 
the WT mice
The colon in CCR7KO mice treated with DSS 
showed less inflammation, despite the absence of CCR7, 
in circumstances that increase the risk of overwhelming 
activation of immune responses. This finding suggests 
Figure 3: CD4+ Treg accumulation in the gut in the absence of CCR7. Foxp3+CD4+Treg were analyzed in the lymphoid 
tissue and peripheral gut tissues. a. representative plots, b. the percentages and c. absolute cell number of Foxp3+CD4+ Tregs from WT or 
CCR7KO mice under steady state conditions, d. the percentage and e. absolute cell number of Foxp3+CD4+ Tregs from WT or CCR7KO 
mice at Day 8 of DSS-induced colitis (n = 4). Student’s t-test.
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that immune suppressive factors other than CD4+ Tregs 
may be involved. IL-10 is a representative cytokine that 
has a regulatory role in gut immunity [18]. Therefore, we 
assessed IL-10 secretion from immune cells in the colon. 
At Day 8 of DSS-induced colitis, the percentage of CD4+ 
T cells expressing CD25+ (CD25+CD4+ T cells), which 
consisted of effector T cells and Tregs, in the colon of 
WT mice was similar to that of CCR7KO mice (Figure 
4a). However, we did not observe significant secretion 
of IL-10 from CD4+ T cell populations comprising of 
Foxp3+CD4+ Tregs, whereas there was significant level 
of IL-10 secretion from CD4- cell population obtained 
from the colon of CCR7KO mice. To further identify cells 
secreting IL-10, we analyzed other cells from the mouse 
LP. We found that IL-10 was not secreted by CD11b+ cells 
comprising macrophages and some myeloid DCs as well 
as B220+ cells comprising of B cells and plasmacytoid 
DCs (Figure 4b). Interestingly, we could find that IL-10 
expressing CD8α+CD8β+ T cells were isolated from colon 
LP in both, WT and CCR7KO mice (Figure 4c and 4d), 
at a higher quantity in CCR7KO as compared to WT. 
IL-10 levels from culture supernatant of colon CD8+ T 
cells were measured. IL-10 secretion of CCR7KO CD8+ 
T cells were significantly enhanced compared to that 
of WT CD8+ T cells (Figure 4e). CD8+ intraepithelial 
lymphocytes isolated from colon could not produce IL-
10 (Supplementary Figure 6). These results suggest that 
CCR7KO immune cells expressed more IL-10 and the 
main IL-10-producing cells were CD8+ T cells in the colon 
LP. 
ccr7Ko cd8+ T cells showed a regulatory effect 
on CD4+ T cells
We investigated whether IL-10-producing CD8+ T 
cells had a regulatory function. When OT-II CD4+ T cells 
were co-cultured with intestinal CD11c+ DCs in presence 
of their cognate antigen, OVA, the OT-II CD4+ T cells 
successfully proliferated and were activated, as assessed 
by CFSE dilution and CD25 expression, respectively 
(Figure 5a-5c). Isolated colon CD8+ T cells during DSS-
induced colitis were added to the culture for activation of 
the OT-II CD4+ T cells. Both, WT and CCR7KO CD8+ T 
cells did not significantly inhibit the proliferation of the 
OT-II CD4+ T cells (Figure 5a and 5b). However, there 
was a significant reduction in CD25 expression by CD4+ 
T cells when they were incubated with CCR7KO CD8+ T 
cells, whereas the expression of CD25 was only slightly 
decreased in WT CD8+ T cells (Figure 5a and 5c). Further, 
these CD8+ T cells suppressed TNF-α secretion in the 
CD4+ T cell culture system (Figure 5d). However, IL-2 
was rather increased during co-culture with WT CD8+ T 
cells, but not CCR7KO CD8+ T cells (Figure 5e). These 
results suggest that IL-10-producing colon CD8+ T cells 
had a regulatory effect on CD4+ T cells but their regulation 
was implemented as subtle way without inhibition of 
CD4+ T cell proliferation. 
To convince the role of IL-10 producing CD8+ 
T cells for immune regulation, we investigated colitis 
following depletion of CD8+ T cells using three times 
treatment of anti-CD8 antibody. Depletion of CD8+ T cells 
was confirmed by analyzing peripheral blood mononuclear 
cells and colon (Supplementary Figure 7). In absence of 
CD8+ T cells, CCR7KO mice showed slightly aggravated 
weight loss (Figure 6a). Although there was no significant 
difference of colon length in WT, the colon length of 
CCR7KO mice in absence of CD8+ cells was significantly 
decreased than that of CCR7KO mice having CD8+ cells 
(Figure 6b). Further, histological examination of colon 
showed that CCR7KO mice showed significantly severe 
inflammatory pathology in absence of CD8+ T cells after 
DSS treatment (Figure 6c and 6d). Inflammatory innate 
cells such as neutrophil, macrophages and myeloid 
dendritic cells in the colon of CCR7KO mice were 
obviously increased in absence of CD8+ T cells (Figure 6e-
6g). These results suggested that intestinal inflammation 
was exacerbated in the CCR7KO mice when CD8+ T 
cells were depleted although the role of CD8+ T cells was 
ambiguous in the WT mice. Collectively, these results 
suggest that CCR7 deficiency increases IL-10 production 
of CD8+ T cells and then causes suppression of intestinal 
inflammation.
Plasmacytoid DCs in the gut LP increased and 
had an immune regulatory function in the absence 
of CCR7
In the intestine, plasmacytoid DCs (pDCs) are 
known to play an immuno-suppressive role by inducing 
oral tolerance [19]. Subsets of CD11c+ DCs in the colon 
LP were analyzed at Day 9 of DSS-induced colitis by 
using plasmacytoid dendritic cell antigen-1 (PDCA-1) as 
a marker for pDCs in order to determine any change in 
the pDC subsets. Thus, we identified 3 subsets of CD11c+ 
DCs: PDCA-1+CD11b- pDCs, PDCA-1lowCD11b+ myeloid 
DCs, and PDCA-1-CD11b- DCs. At steady state, the 
percentage of pDCs was lower in both, WT and CCR7KO 
groups, as compared to those after DSS treatment, 
although the CCR7KO group had higher numbers and 
proportion of pDCs than the WT group (Figure 7a-
7b, Supplementary Figure 8). When treated with DSS, 
pDCs increased in the colon of both, WT and CCR7KO 
mice. Interestingly, CCR7 deficiency resulted in a higher 
percentage of pDCs as compared to that in the WT mice, 
in the DSS-induced colitis model. CD11b+ DCs were 
slightly but not significantly decreased during intestinal 
inflammation. 
To investigate the role of increased pDCs for 
immune regulation, mice were administered with 2% 
DSS and pDCs were depleted by anti-PDCA1 antibody. 
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Figure 4: CCR7KO CD8+ T cell in the lamina propria of gut express higher level of IL-10. At Day 8 of DSS-induced colitis, 
lymphocytes and IL-10-secreting cells were analyzed from the colon. a. CD25 expression and IL-10 secretion by CD4+ T cells, b. IL-10 
secretion on CD11b+ myeloid cells and B220+ B cells, c.-d. IL-10 secretion by lamina propria CD8+ T cells, Student’s t-test, *p < 0.05, ***p 
< 0.001 e. IL-10 production by CD8+ T cells isolated from colon of WT or CCR7KO mice. Student’s t-test, ***p < 0.001.
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Figure 5: CCR7KO CD8+ T cells show regulatory effect on CD4+ T cells. OT-II CD4+ T cells from naïve OT-II spleen and 
CD11c+ DCs isolated from the intestine were incubated with 200 µg/ml OVA in the presence of colon CD8+ T cells with DSS-induced 
colitis. a. CFSE dilution and CD25 expression on OT-II CD4+ T cells, representative data from 5 repeated experiments, b. the proliferation 
of OT-II CD4+ T cells was analyzed via CFSE dilution, c. the activation of OT-II CD4+ T cells was analyzed in terms of CD25 expression. 
At day 5 of culture, the culture supernatants were analyzed for cytokine production, d. TNF-α and e. IL-2. ns, not significant; *p < 0.05; 
one-way ANOVA.
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Figure 6: CCR7KO mice showed exacerbated colitis in absence of CD8+ T cells. Mice were treated with 2% DSS for 5 days 
followed by switching to drinking water. Anti-CD8 antibody was treated tree times at indicated time point (arrow). At day 10 of DSS-
induced colitis, inflammation was analyzed from the colon (n = 4). a. body weight changes, b. colon length; ns, not significant; *p < 0.05; 
one-way ANOVA, c. representative H&E images of distal colon (n = 4), d. pathological grade from histological examination of colon 
stained with H&E; Student’s t-test, e. Gr-1highCD11b+ neutrophil population analysis, f. F4/80+CD11b+ macrophages analysis, g. dendritic 
cell analysis. Student’s t-test.
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We confirmed that pDCs in colon were considerably 
reduced following treatment of anti-PDCA1 antibody 
(Supplementary Figure 9). In absence of pDCs, CCR7KO 
mice showed significantly aggravated weight loss (Figure 
7c). In addition, the colon length of CCR7KO mice was 
significantly decreased by the pDCs depletion (Figure 7d). 
Further, histological examination of colon showed that 
CCR7KO mice showed significantly severe inflammatory 
pathology in absence of pDCs after DSS treatment 
(Figure 7e and 7f). These results suggested that intestinal 
inflammation was exacerbated in the CCR7KO mice with 
reduced pDCs. Collectively, these results suggest that 
increased pDCs in large intestine of CCR7KO mice have 
regulatory effects against DSS-induced colitis. 
dIscussIon
The intestinal immune system has evolved a 
regulatory system involving CD4+ Tregs expressing Foxp3 
to prevent unnecessary immune reactions to harmless 
external stimuli such as commensals and food. In order to 
exert their regulatory function, Tregs need to migrate from 
the periphery to draining lymph nodes via the interaction 
of CCL19 or CCL21 with CCR7 receptors. CCR7 is 
highly expressed on various kinds of immune cells such as 
naïve and central memory T cells, B cells, and mature DCs 
as well as CD4+ Tregs [12]. Therefore, CCR7 deficiency 
generally results in the attenuation of immune responses 
due to the impaired migration of DCs and abnormal 
secondary lymphoid organ architecture. Despite impaired 
DC migration, effector T cells including both CD4+ and 
CD8+ T cells rather increased in the peripheral tissue in 
the CCR7KO mice which exacerbated disease condition 
for airway allergy and nephrotoxic serum nephritis in the 
CCR7KO mice [20, 21]. Therefore, impaired migration 
of Treg and peripheral accumulation of effector T cells 
could lead to hyper-immune responses in CCR7KO 
mice. Therefore, CCR7 deficiency was expected to cause 
functional defect of CD4+ Tregs and elicit severe intestinal 
pathology in response to inflammatory stimuli. 
Unexpectedly, in this study we found that CCR7KO 
mice showed less severe inflammation in the gut as 
compared to WT mice in a DSS-induced colitis mouse 
model. Therefore, we analyzed other regulatory factors 
to explain the attenuated intestinal inflammation of 
CCR7KO mice. IL-10, an immunosuppressive cytokine 
is produced by CD8+ and not CD4+ T cells in the colon 
of CCR7KO mice. These IL-10-producing CD8+ T cells 
inhibited the activation of CD4+ T cells and the subsequent 
TNF-α secretion. In addition, regulatory pDCs were also 
significantly increased in CCR7KO colon during colitis. 
Depletion of CD8+ T cells and pDCs exacerbated colitis 
in CCR7KO mice. These results suggested that regulatory 
CD8+ T cells and pDCs could maintain gut homeostasis, 
which compensated for attenuated Foxp3+CD4+ Tregs 
without CCR7. 
IL-10-expressing CD8+ T cell numbers in the 
colon of CCR7KO mice were dramatically higher than 
those in the colon of WT mice during inflammation, 
although they were also found at low levels in the steady 
state. This might explain why colitis in CCR7KO mice 
was mitigated despite the defective function of Foxp3+ 
Tregs. Suppressive CD8+ T cells expressing IL-10 and 
IFN-γ were first described in the 1970s and they have a 
long history in immunology [22, 23]. However, the lack 
of potential markers for regulatory CD8+ T cells delayed 
further investigations. Non-classical MHC class Ib (Qa-1)-
restricted CD8αα+ T cells can repress autoimmune diseases 
by not only direct killing of effector T cells via perforin 
but also with the help of immunosuppressive cytokines 
such as TGF-β and IL-10 [24, 25]. In our previous report, 
we identified regulatory CD8αβ+ T cells expressing IL-10, 
IL-9, IL-13, and IFN-γ in the SI, which could be secreted 
by non-migratory CX3CR1
+ phagocytic cells independent 
of MLN [26]. These CD8+ T cells inhibited the activation 
and differentiation of inflammatory CD4+ T cells via IL-10 
expression in the colitis model. Collectively, CD8αβ+ T 
cells expressing IL-10 were enhanced when the function of 
CD4+ Tregs was reduced and thus played a compensatory 
role in the gut to bring about immune regulation.
IL-10 is one of the most common cytokines 
implicated in the maintenance of intestinal homeostasis. 
IL-10−/− mice developed spontaneous, progressive colitis, 
which eventually affected the small intestine as well [27, 
28]. IL-10 acts not only to control effector T cell function, 
but also to suppress the proinflammatory activity of 
myeloid cells, since the IL-10 receptor is expressed on 
both innate and adaptive immune cells as well as on non-
hematopoietic cells [29]. STAT3 protein is essential for 
both, the anti-proliferative and the anti-inflammatory 
effects of IL-10 on macrophages [30]. IL-10 also reduces 
the expression of co-stimulatory surface molecules on 
macrophages [31]. Although IL-10 achieves control 
of adaptive immune response indirectly via antigen-
presenting cell signaling, IL-10 directly promotes the 
maintenance, expansion, and function of Treg cells as 
well, via the IL-10 receptor [32]. Diverse cellular sources 
of IL-10 have been identified in the gut, including several 
different subsets of CD4+ T cells, including Foxp3+ and 
Foxp3− cells [33, 34] as well as CD8+ T cells. CD8+ T 
cells cultured in the presence of IL-4 acquire an IL-10-
producing phenotype and after adoptive transfer, these 
cells are capable of amelioration of colitis [35]. In addition, 
IL-10-producing CD8αβ+ T cells in the LP and epithelium 
of SI were produced by CX3CR1
hi LP macrophages [26]. 
Additionally, B cells are a functional source of IL-10 [36], 
as are CX3CR1
hi LP macrophages [37-39]. In this study, the 
main cellular source of IL-10 in the inflamed CCR7KO 
colon was revealed as CD8αβ+ T cells, which appear to 
be a major player in immune regulation in the absence of 
intact Tregs.
pDCs, unlike conventional DCs, express B220 and 
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Figure 7: Plasmacytoid DCs in the lamina propria of gut expanded and had an immune regulatory role in the absence 
of CCR7. At Day 9 of DSS-induced colitis, DC subsets from the colon were analyzed. a. PDCA-1+ plasmacytoid DC versus CD11b+ DCs, 
representative data from 3 repeated experiments, b. percentage of DC subsets among CD11c+ DCs in the colon. *p < 0.05, **p < 0.01, ***p < 
0.001 compared with matched control group using one-way ANOVA. Mice were treated with 2% DSS for 5 days and anti-PDCA1 antibody 
was treated every other day (arrow). At day 9 of DSS-induced colitis, inflammation was analyzed from the colon (n = 5). c. body weight 
changes, d. colon length; *p < 0.05; Student’s t-test, (c) pathological grade from histological examination of colon stained with H&E; **p < 
0.01; Student’s t-test, (d) representative H&E images of distal colon (n = 5).
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PDCA-1 [40] in addition to low levels of CD11c, CD8α+, 
and CD11b-. pDCs are known to play a crucial role in 
innate immunity against viral infection by producing 
type-I interferons including IFN-α and IFN-β [41]. In the 
gut, they interestingly have a regulatory function during 
conditions such as oral tolerance [42]. pDCs mediate 
anti-inflammatory responses subsequent to TLR2-
microbial polysaccharide A engagement [43]. Type-I 
interferon secreted by pDCs has shown to support CD4+ 
Treg function and repress colitis [44, 45]. During DSS-
induced colitis, significantly higher numbers of pDCs 
were present in the colon of CCR7KO mice than that in 
WT mice. Exacerbated colitis by the depletion of pDCs 
suggested that these pDCs exist in colon were involved 
in the maintenance of intestinal immune homeostasis. 
However, it is unclear if these pDCs of CCR7KO mice 
had any direct or indirect influence on IL-10-producing 
CD8+ T cells.
There is no doubt that Foxp3+CD4+ Tregs are 
master regulators of immune homeostasis. The intestinal 
environment is one of the most significant sites for 
immune suppression in our body. In fact, the proportion 
of Foxp3+CD4+ Tregs amongst peripherally circulating 
CD4+ T cells is highest in the gut, especially the colon. 
However, functional defect of Foxp3+CD4+ Tregs does 
not lead to drastic pathological disease in response to 
inflammatory stimuli since there are alternatives, such 
as CD8+ Tregs and regulatory DCs who take over when 
the need arises. Collectively, these results suggest that the 
intestine contains an intricate regulatory mechanism to 
maintain immune homeostasis. 
MAterIAls And Methods
Mice
All experiments were approved by the Institutional 
Animal Care and Use Committee of Kangwon National 
University and Ajou University. WT C57BL/6 mice 
were purchased from Charles River Laboratories (Orient 
Bio Inc., Sungnam, Korea). CCR7-/- mice (C57BL/6 
background) were purchased from Jackson Laboratories 
(Bar Harbor, ME). All mice used in the study were at 6 
weeks of age. The mice were kept in the Animal Center for 
Pharmaceutical Research at Kangwon National University 
and Ajou University. 
Colitis induction
To induce colitis in mice, 2% DSS (MP Biomedicals, 
Solon, OH) in autoclaved drinking water were treated for 
5days and then changed into drinking water without DSS. 
For depletion of CD8+ T cells, hybridomas producing 
depleting anti-CD8 (2.43) mAb were obtained from the 
ATCC and mice were treated three times as previously 
described [46]. For depletion of pDCs, anti-PDCA-1 
antibody (eBiosciences) was treated every other day from 
day 1.
Cell isolation
To isolate mononuclear cells, the spleen (SP), 
peripheral lymph nodes (PLN), mesenteric lymph nodes 
(MLN), and Peyer’s Patches (PPs) were homogenized 
and treated with RBC lysis buffer (Sigma-Aldrich, St. 
Louis, MO), as necessary. To obtain mononuclear cells 
from the lamina propria (LP) of the small intestine (SI) 
and colon, the intestine was inverted onto polyethylene 
tubes (Becton Dickinson, Franklin Lakes, NJ) and washed 
3 times with calcium- and magnesium-free phosphate-
buffered saline (PBS). The intestines were treated with 1 
mM dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO) 
to remove mucus, 30 mM EDTA to remove epithelial 
cells, and finally digested with 108 U/ml (for colon) or 36 
U/ml (for SI) type IV collagenase (Sigma-Aldrich) for 90 
min at 37°C. LP cells were then treated with discontinuous 
density gradient containing 66% and 44% Percoll (GE 
Healthcare Life sciences, Uppsala, Sweden) for T cells 
and Opti-prep (Axis-Shield, Oslo, Norway) with fetal 
bovine serum (FBS) layered on top for DCs. To evaluate 
IL-10 production from colon CD8+ T cells, CD8+ T cells 
were purified using CD8α+ MicroBeads (Miltenyi Biotec, 
Auburn, CA) and then stimulated with anti-CD3/ anti-
CD28 antibody for overnight. The IL-10 level of culture 
supernatant were measured by ELISA (eBioscience, San 
Diego, CA).
Histology
The colons were washed with PBS and fixed in 4% 
formaldehyde for 1 h at 4°C. The tissues were dehydrated 
by gradually soaking them in alcohol and xylene and then 
embedded in paraffin. The paraffin-embedded specimens 
were cut into 5-µm sections, stained with hematoxylin and 
eosin, and viewed with a digital light microscope DS-Fi2 
(Nikon, Tokyo, Japan). 
Flow cytometry
Isolated cells were incubated in 2% FBS and 
Fc block (BD Bioscience) for 20 min at 4°C and 
then stained with fluorescent-conjugated antibody. 
Most Abs used for flow cytometry analysis were 
purchased from BD Biosciences except for anti-mouse 
F4/80-PE (eBioscience), anti-mouse/rat Foxp3-APC 
(eBioscience), and anti-mouse CD317(BST2, PDCA-1)-
PE (eBioscience). Data were obtained using FACSCanto 
(BD Bioscience) and analyzed with FlowJo software (Tree 
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Star, Ashland, OR). For intracellular staining for IL-10, 
the cells were stimulated with PMA/ionomycin or anti-
CD3 antibody and then fixing and permeabilization buffer 
were used as per manufacturer instructions.
T cell inhibition assay
OT-II CD4+ T cells were isolated from the spleen 
of OT-II mice by using the CD4+ T cell Isolation Kit II 
(Miltenyi Biotec). OT-II CD4+ T cells were labeled with 1 
μM CFSE (Molecular probe, Eugene, OR). CD8+ T cells 
were isolated from the colon and purified using CD8α+ 
MicroBeads (Miltenyi Biotec) as per the manufacturer 
instructions. CD11c+ DCs were isolated from the SI and 
further prepared using CD11c+ MicroBeads (Miltenyi 
Biotec) as per manufacturer instructions. The purity 
following bead isolation was >90%. Subsequently, 2 × 105 
OT-II CD4+ T cells and 1x105 DCs were co-cultured with 
200 µg/ml OVA in presence of 2 × 105 WT or CCR7KO 
CD8+ T cells for 5 days. The CFSE level and CD25 
expression on OT-II CD4+ T cells were analyzed by flow 
cytometry. The culture supernatants were analyzed for 
cytokine production using murine inflammatory CBA kit 
(BD biosciences) as per manufacturer instructions.
Statistics
Student’s t-test was used to compare differences 
between the two groups. To compare multiple groups, we 
performed one-way ANOVA followed by Tukey’s post hoc 
test. For survival rate, Log-rank (Mantel-Cox) test were 
used. Values of p < 0.05 were considered to be significant.
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